Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor- positive breast cancer cells inhibits proliferation both in vitro and in vivo

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5315-5322

  Tang, Careen K ^a,b   Concepcion, Xiao Zheng Wu ^a   Milan, Melissa ^a   Gong, Xiaoqi ^a   Montgomery, Elizabeth ^a   Lippman, Marc E ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GENE PRODUCT; PROTEIN TYROSINE KINASE; RIBOZYME; TYROSINE KINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL PROLIFERATION; COLONY FORMATION; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; DOWN-REGULATION; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEUREGULIN-1; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RNA, CATALYTIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032718015     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer cells. Br. Med. Bull., 47: 87-98, 1991.
2. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198: 165-184, 1994.
3. Lemoine, N. R., Barnes, D. M., Hollywood, D. P., Hughes, C. M., Smith, P., Dublin, E., Prigent, S. A., Gullick, W. J., and Hurst, H. C. Expression of the ErbB3 gene product in breast cancer. Br. J. Cancer, 66: 1116-1121, 1992.
4. Xu, Y. H., Ishii, S., Clark, A. J., Sullivan, M., Wilsm, R. K., Ma, D. P., Roe, B.A, Merlino, G. T., and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs over-produced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
5. r tumor antigen. Nature (Lond.) 312: 513-516, 1984.
6. Kraus, M. H., Issing, W., Miki, T., Popeson, N. C., and Aaronson, S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
7. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor related gene. Proc. Natl. Acad. Sci. USA, 87: 4905-4909, 1990.
8. Plowman, G. D., Colouscou, J. M., Whitney, G. S., Green, J. M., Carton, G. W., Foy, L., Newbaner, M. G., and Shoyab, M. Ligand-specific activation of HER4/ p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
9. erbB-2. Science (Washington DC), 256: 1205-1210, 1992.
10. Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Benlevy, R., Koski, R. A., Lu, H. S., and Yarden, Y. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell, 69: 559-572, 1992.
11. Falls, D. G., Rosen, K. M., Corfas, G., Lane, W. S., and Fischbach, G. D. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family. Cell, 72: 801-815, 1993.
12. Marchionni, M. A., Goodeart, A. D. J., Chen, M. S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, J. B., Hsuan, J. J., Totty, N. F., Otsu, M., McBurney, R. N., Waterfield, M. D., Stroobant, P., and Gwynne, D. Glial growth factors are alternatively spliced erbB-2 ligands expressed in the nervous system. Nature (Lond.), 362: 312-318, 1993.
13. Lupu, R., Colomer, R., Zugmaier, G., Sarup, J., Shepard, M., Slamon, D., and Lippman, M. E. Direct interaction of a ligand for the erbB-2 oncogene product with the EGF receptor and p185erbB-2. Science (Washington DC), 249: 1552-1555, 1990.
14. erbB-4. Nature (Lond.), 366: 473-475, 1993.
15. Carraway, K. L., III, Sliwkowski, M. X., Akita, R. W., Platko, J. V, Guy, P. M., Nuijens, A., Diamonti, A. J., Vandlen, R. L., Cantley, L. C., and Cerione, R. A. The erbB-3 gene product is a receptor for Heregulin. J. Biol. Chem., 269: 14303-14306, 1994.
16. Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. ErbB-3 and erbB-4 function as the respective low and high affinity receptors of all neu differentiation factor/heregulin isoforms. J. Biol. Chem., 269: 40, 25226-25233, 1994.
17. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., and Yarden, Y. Cell type specific interaction of neu differentiation factor (NDF/Heregulin) with Neu/Her-2 suggests complex ligand-receptor relationships. EMBO J., 12: 961-971, 1993.
18. Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., and Carraway, K. L., III. Coexpression of erbB-2 and erbB-3 proteins reconstitute a high affinity receptor for heregulin. J. Biol. Chem., 269: 14661-14665, 1994.
19. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J., 16: 1647-1655, 1997.
20. Pinkas-Kramarki, R., Shelly, M., Glathe, S., Ratzkin, B., and Yarden, Y. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J. Biol. Chem., 271: 19029-19032, 1996.
21. Pinkas-Kramarki, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B., Sela, M., and Yarden, Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15: 2452-2467, 1996.
22. Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., and Klagsbrun, M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Washington DC), 251: 936-939, 1991.
23. Shing, Y., Christofori, G., Hanahan, D., Ono, Y., Sasada, R., Igarashi, K., and Folkman, J. Betacellulin: a mitogen from pancreatic cell tumors. Science (Washington DC), 259: 1604-1607, 1993.
24. Alimandi, M., Wang, L. M., Bottaro, D., Lee, C. C., Kuo, A., Frankel, M., Di Fiore, P. P., Tang, C., Lippman, M., and Pierce, J. H. EGF-mediated signal transduction through co-expressed ErbB-2 and ErbB-3 receptors. EMBO J., 16: 5608-5617, 1997.
25. Elenius, K., Paul, S., Allison, G., Sun, J., and Klagsbrun, M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J., 16: 1268-1278, 1997.
26. Riese, D. J., II, Bermingham, Y., van Raaij, T. M., Buckley, S., Plowman, G. D., and Stern, D. F. Betacellulin activates the epidermal growth factor receptor and ErbB-4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin β. Oncogene, 12: 345-353, 1996.
27. Sawyer, C., Hiles, I., Page, M., Crompton, M., and Dean, C. Two erbB-4 transcripts are expressed in normal breast and in most breast cancers. Oncogene, 17: 919-924, 1998.
28. Cohen, B. D., Green, J. M., Foy, L., and Fell, H. P. HER4-mediated biological and biochemical properties in NIH3T3 cells. J. Biol. Chem., 271: 30897-30903, 1996.
29. Vogt, U., Bielawske, K., Schlotter, C. M., Bosse, U., Falkiewicz, B., and Podhajska, A. J., Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary breast cancer. Gene (Amst.), 223: 375-380, 1998.
30. Gilbertson, R. J., Clifford, S. C., MacMeekin, W., Wright, C., Perry, R. H., Kelly, P., Pearson, A. D. J., and Lunec, J. Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. Cancer Res., 58: 3932-3941, 1998.
31. Peles, E., and Yarden, Y. Neu and its ligands: from an oncogene to neural factors. BioEssays, 15: 815-824, 1993.
32. Gassmann, M., Casagranda, F., Orioll, D., Simon, H., Lal, C., Klein, R., and Lemke, G. Aberrant neural and cardiac development in mice lacking the ErbB-4 neuregulin receptor. Nature (Lond.), 378: 390-394, 1995.
33. Tang, C. K., Goldstein, D. J., Payne, J., Czubayko, F., Alimandi, M., Wang L-M., Pierce, J. H., and Lippman, M. E. ErbB-4 ribozymes abolish neuregulin induced mitogenesis. Cancer Res., 58: 3415-3422, 1998.
34. Mehta, C., and Patel, N. StatXact3 for Windows. Cambridge, MA: Cytel Software Corp.
35. McCall, M. J., Hendry, P., and Jennings, P. A. Minimal sequence requirements for ribozyme activity. Proc. Natl. Acad. Sci. USA, 89: 5710-5714, 1992.
36. Di Fiore, P. P., Segatto, O., Taylor, W. G., Aaronason, S. A., and Pierce, J. H. EGF-receptor and ErbB-2 tyrosine kinase domains confer cell specifically for mitogenic signaling. Science (Washington DC), 248: 79-83, 1990.
37. Groenen, L. C., Nice, E. C., and Burgess, A. W. Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors, 11: 235-257, 1994.
38. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
39. Waterman, H., Sabanai, I., Geiger, B., and Yarden, Y. Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem., 273: 13819-13827, 1998.
40. Knowlden, J. M., Gee, J. M. W., Seery, L. T., Farrow, L., Gullick, W. J., Ellis, I. O., Blamey, R. W., Robertson, J. F. R., and Nichoson, R. I. c-erbB-3 and c-erbB-4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene, 17: 1949-1957, 1998.
41. Jannot, C. B., Beerli, R. R., Mason, S., Gullick, W. J., and Hynes, N. E. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene, 13: 275-282, 1996.
42. Kataoka, H., Joh, T., Kasugai, K., Okayama, N., Moriyama, A., Asai, K., and Kato, T. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa. Life Sci., 63: 553-564, 1998.
43. Krane, I. M., and Leder, P. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene, 12: 1781-1788, 1996.
44. Bacus, S. S., Chin, D., Yarden, Y., Zelnick, C. R., and Stern, D. F. Type I receptor tyrosine kinases are differentially phosphorylaled in mammary carcinoma and differentially associated with steroid receptors. Am. J. Pathol., 148: 549-558, 1996.
45. Bacus, S. S., Hubernam, E., Chin, D., Kiguchi, K., Simpson, S., Lippman, M., and Lupu, R. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ., 3: 401-411, 1992.
46. Bacus, S. S., Gudkov, A. V., Zelnick, C. R., Chin, D., Stern, R., Stancovski, I., Peles, E., Baruch, B., Farbstein, H., Lupu, R., Wen, D., Sela, M., and Yarden, Y. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res., 53: 5251-5261, 1993.